ISRV is pleased to announce that preparations are well underway for the 8th ISRV Antiviral Group (AVG) Conference and the 3rd International Meeting on Respiratory Pathogens (IMRP), taking place from September 17–20, in Singapore
This major international meeting will bring together leading experts, researchers, clinicians, policymakers, and industry representatives from across the globe. Over four days, participants will share the latest advances in respiratory virus science, antiviral therapies, vaccines, diagnostics, and public health strategies.
The combined IMRP & AVG meeting is recognized as a unique forum for knowledge exchange and collaboration. The program is designed to highlight cutting-edge science and provide a platform for cross-disciplinary discussions. Topics will include pathogen genomics and surveillance, novel therapeutic approaches, next-generation vaccine development, and pandemic preparedness. The meeting will also feature regulatory and industry perspectives, ensuring that both research and real-world implementation are addressed.
Beyond the scientific sessions, the conference will provide opportunities to strengthen networks, build collaborations, and engage with colleagues from around the world. Attendees will benefit from plenary talks, oral presentations, poster sessions, and interactive workshops designed to stimulate dialogue and advance collective understanding of the challenges and opportunities in the field.
With respiratory viruses continuing to pose significant global health threats, IMRP & AVG 2025 offers a timely and vital space for the scientific and medical community to come together and shape the future of prevention, treatment, and response.
